Oklahoma City, OK4 Active Studies

Advanced Solid Tumors Clinical Trials in Oklahoma City, OK

Find 4 actively recruiting advanced solid tumors clinical trials in Oklahoma City, OK. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
693
Enrolling

Recruiting Advanced Solid Tumors Studies in Oklahoma City

RecruitingOklahoma City, OKNCT05525247

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination

This is a Phase 1/2, open-label, multicenter, dose escalation and expansion study, evaluating the safety, tolerability, pharmacokinetic, preliminary anti-tumor activity, and effects on pharmacodynamic...

420 participants
Selecxine
View Study Details
RecruitingOklahoma City, OKNCT04219254

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors (KEYNOTE-A04)

Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRIIB), in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors Previously Treated with Anti-PD-1 or Anti-PD-L1...

197 participants
BioInvent International AB
View Study Details
RecruitingOklahoma City, OKNCT05431270

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

This is a first-in-human, Phase 1/2, open-label, study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of Mavrostobart (PT199) alone and in ...

40 participants
Phanes Therapeutics
View Study Details
RecruitingOklahoma City, OKNCT04550494

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

This phase II trial studies if talazoparib works in patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and has...

36 participants
National Cancer Institute (NCI)
View Study Details

About Advanced Solid Tumors Clinical Trials in Oklahoma City

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 4 advanced solid tumors clinical trials recruiting participants in Oklahoma City, OK. These studies are seeking a combined 693 participants. Research is being sponsored by Selecxine, BioInvent International AB, Phanes Therapeutics and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Oklahoma City — FAQ

Are there advanced solid tumors clinical trials in Oklahoma City?

Yes, there are 4 advanced solid tumors clinical trials currently recruiting in Oklahoma City, OK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Oklahoma City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oklahoma City research site will contact you about next steps.

Are clinical trials in Oklahoma City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oklahoma City studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 4 active trials in Oklahoma City are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov